The Maple Syrup Urine Disease (MSUD) Gene Panel by NGS analyzes genes involved in branched-chain amino acid metabolism, helping detect inherited defects that lead to toxic buildup of leucine, isoleucine, and valine. Using an EDTA blood sample, this test identifies mutations responsible for classic, intermediate, or variant forms of MSUD. Metropolis Healthcare uses advanced next-generation sequencing to ensure accurate and comprehensive variant detection. The results assist in early diagnosis, dietary planning, and timely clinical management
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0219
Frequently Asked Questions (FAQ's):
What does the MSUD Gene Panel include at Metropolis Healthcare?
It evaluates key genes involved in branched-chain amino acid breakdown using high-precision next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted genes to detect mutations linked to MSUD.
Who should consider taking this test at Metropolis Healthcare?
Infants with poor feeding, lethargy, seizures, or a family history of MSUD should be evaluated using this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is sufficient for accurate DNA extraction and sequencing.
How long does Metropolis Healthcare take to provide results?
Results are typically available within a standard genetic testing timeframe after detailed sequencing and expert interpretation.
Why choose Metropolis Healthcare for MSUD testing?
Metropolis Healthcare offers comprehensive gene coverage, high sequencing accuracy, and clinically actionable reporting.
Does Metropolis Healthcare provide post-test guidance?
Yes, expert genetic insights accompany the report to assist with dietary management and family screening.
Is this test suitable for newborns at Metropolis Healthcare?
Yes, the panel is appropriate for newborns, children, and adults with suspected metabolic disorders like MSUD